LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K203136
    Device Name
    Diazyme PLAC® Test for Lp-PLA2 Activity
    Manufacturer
    Diazyme Laboratories Inc.
    Date Cleared
    2021-08-06

    (290 days)

    Product Code
    NOE
    Regulation Number
    866.5600
    Type
    Special
    Panel
    Clinical Chemistry
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    Diazyme PLAC**®** Test for Lp-PLA2 Activity

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Diazyme PLAC® Test for Lp-PLA2 Activity is an enzyme assay for the in vitro quantitative determination of Lp-PLA2 (lipoprotein-associated phospholipase A2) activity in EDTA plasma and serum on automated clinical chemistry analyzers. Lp-PLA2 activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events.

    Device Description

    Not Found

    AI/ML Overview

    The provided text is a 510(k) clearance letter for a medical device, the Diazyme PLAC® Test for Lp-PLA2 Activity. It largely focuses on regulatory aspects and the indication for use, not detailed study data or acceptance criteria. Therefore, I cannot extract the information required to populate all sections of your request from the provided text.

    Specifically, the document does not include:

    • A table of acceptance criteria and reported device performance.
    • Sample sizes used for test sets.
    • Data provenance (country, retrospective/prospective).
    • Number of experts or their qualifications for ground truth.
    • Adjudication methods.
    • Information on MRMC studies or effect sizes.
    • Standalone performance information.
    • Type of ground truth used.
    • Sample size for training sets.
    • How ground truth for training was established.

    The only relevant information I can derive is the device name and its intended use:

    Device Name: Diazyme PLAC® Test for Lp-PLA2 Activity

    Indication for Use: "The Diazyme PLAC® Test for Lp-PLA2 Activity is an enzyme assay for the in vitro quantitative determination of Lp-PLA2 (lipoprotein-associated phospholipase A2) activity in EDTA plasma and serum on automated clinical chemistry analyzers. Lp-PLA2 activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events."

    To fulfill your request for detailed acceptance criteria and study information, you would need access to the full 510(k) summary or the premarket submission itself, as this letter is merely the FDA's clearance notification.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1